This ticker has not been starred yet LCTX Lineage Cell Therapeutics, Inc.
Biological Products (no Diagnostic Substances)
Book value per $ invested $ 0.06
Leverage 76.80%
Market Cap $ 329.9m
PE 0.00
Dividend Yield 0.00%
Profit $ -67.3m
Margin -677.02%

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment of degenerative diseases in the United States and internationally. The company is headquartered in Carlsbad, California.

Subscribe Now For Access - Only $1.99 Per Month